CI
Cingulate Inc.
CINGW · NASDAQ
$0.01 +0.00% (+$0.00)
1M -24.05%
Market Cap $40.5K
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$0.01
66.7% upside
Current Price
$0.006
Undervalued Fair Value Overvalued
According to Bulios Fair Price, CINGW is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
2/9Valuation
100 /100
Cheap P/B 0.00x
P/E N/A
P/FFO N/A
Growth
0 /100
Declining Book val. growth 13.54%
EPS growth N/A
FCF growth N/A
Profitability
-
N/A Gross margin N/A
FCF margin N/A
Net margin N/A
Quality
2 /100
Poor ROIC 2.00%
Asset turnover 0.00x
ROA 0.09%
Debt
70 /100
Low Debt/Equity 52.14x
Net debt/EBITDA -139.79x
Current ratio 3,500.01x
Stability
19 /100
Unstable Beta -0.91x
Profitable years 0
EPS volatility 565.01%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about CINGW
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Shane J. Schaffer
Employees
14
Headquarters
Kansas City
Upcoming events
18 NOV
Earnings
Upcoming earnings report